119 related articles for article (PubMed ID: 28457063)
1. Prognostic Factors in Differentiated Thyroid Cancer Revisited.
Glikson E; Alon E; Bedrin L; Talmi YP
Isr Med Assoc J; 2017 Feb; 19(2):114-118. PubMed ID: 28457063
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognostic factors for differentiated thyroid cancer.
Duntas L; Grab-Duntas BM
Hell J Nucl Med; 2006; 9(3):156-62. PubMed ID: 17160155
[TBL] [Abstract][Full Text] [Related]
3. New insights in risk stratification of differentiated thyroid cancer.
Papaleontiou M; Haymart MR
Curr Opin Oncol; 2014 Jan; 26(1):1-7. PubMed ID: 24285100
[TBL] [Abstract][Full Text] [Related]
4. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
[TBL] [Abstract][Full Text] [Related]
8. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
10. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
11. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
[TBL] [Abstract][Full Text] [Related]
14. Identification of a cut-off for the MACIS score to predict the prognosis of differentiated thyroid carcinoma in children and young adults.
Jang HW; Lee JI; Kim HK; Oh YL; Choi YL; Jin DK; Kim JH; Chung JH; Kim SW
Head Neck; 2012 May; 34(5):696-701. PubMed ID: 21748817
[TBL] [Abstract][Full Text] [Related]
15. [Differentiated thyroid cancer--staging and prognostic systems].
Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
[TBL] [Abstract][Full Text] [Related]
16. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Wong RM; Bresee C; Braunstein GD
Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
[TBL] [Abstract][Full Text] [Related]
17. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases in differentiated thyroid cancer under 2 cm.
Reddy RM; Grigsby PW; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1050-4; discussion 1054-5. PubMed ID: 17188156
[TBL] [Abstract][Full Text] [Related]
19. The impact of age on thyroid cancer staging.
Kazaure HS; Roman SA; Sosa JA
Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):330-334. PubMed ID: 30048260
[TBL] [Abstract][Full Text] [Related]
20. Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.
Morbelli S; Ferrarazzo G; Pomposelli E; Pupo F; Pesce G; Calamia I; Fiz F; Clapasson A; Bauckneht M; Minuto M; Sambuceti G; Giusti M; Bagnasco M
J Endocrinol Invest; 2017 Apr; 40(4):417-424. PubMed ID: 27844413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
